Australia Group Urges Early-Warning System For Problem Drugs
This article was originally published in PharmAsia News
Executive Summary
The Australian Commission on Safety and Quality in Health Care is calling for a federal law to require agencies to cross-check for possible lethal side effects of new drugs. The group said the Pharmaceutical Benefits Scheme and Medicare hold huge amounts of information on illnesses and deaths attributed to medication problems. Even with that information, the nation has no system for early recognition of adverse- event patterns. The health and safety commission also said high-risk groups such as diabetics would benefit the most from advance knowledge of adverse events if patient details were linked to problem medications. (Click here for more
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.